Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

Lepodisiran, a new drug, slashed levels of “stealthy cholesterol”—a hidden heart risk affecting 1 in 5 people—by up to 95% in ...

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

HCM and DCM are among the most common inherited heart diseases. Both can cause serious problems like heart failure and sudden ...

Treating patients earlier with a combination of statins and the cholesterol-lowering drug ezetimibe could prevent thousands of new heart attacks, strokes, and death over a decade, according to ...

In conclusion, heart failure is a condition that should not be taken lightly. But by learning the early signs—like shortness ...

The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...